Pamela Kulback, MD
Diagnostic Radiology · Birmingham, ALNPI 1942282173
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 283 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by Novo Nordisk at 25.5% of the total. Reporting peaked in 2019 at $2,097 and has fallen 71.4% since, to $600 in 2025. Among diagnostic radiology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 283 payments — averaging $23.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Galderma Laboratories, L.p.$770
- Amgen$549
- AstraZeneca$455
- Lilly USA, LLC$446
- Amarin Pharma, Inc.$330
- plus $2K from 22 others
What the payments were for
- Food & beverage$6,586100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 95 | $1,680 |
| Galderma Laboratories, L.p. | 30 | $770 |
| Amgen | 14 | $549 |
| AstraZeneca | 4 | $455 |
| Lilly USA, LLC | 21 | $446 |
| Amarin Pharma, Inc. | 20 | $330 |
| Merz North America, Inc. | 6 | $316 |
| Pfizer | 5 | $260 |
| Merck | 13 | $220 |
| Johnson & Johnson | 13 | $214 |
| AbbVie(2 entities) | 5 | $140 |
| Exact Sciences | 8 | $140 |
| E.r. Squibb & Sons, L.L.C. | 6 | $122 |
| Dexcom, Inc. | 7 | $120 |
| Corcept Therapeutics | 1 | $119 |
| Optinose US, Inc. | 1 | $117 |
| Phathom Pharmaceuticals, Inc. | 5 | $117 |
| Boehringer Ingelheim | 6 | $94 |
| Xeris Pharmaceuticals, Inc. | 4 | $86 |
| GSK | 5 | $76 |
| Novartis | 4 | $60 |
| Eisai Inc. | 3 | $47 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Bayer | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Abbott | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,598 in reported general payments places this provider in the 95th percentile of 448 diagnostic radiology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other diagnostic radiology in Birmingham
- Jesse JonesBirmingham$161K
- Jubal WattsBirmingham$113K
- Jonathan McConathyBirmingham$34K
- George NewmanBirmingham$15K
- Alyssa KnightBirmingham$14K
- Michelle RobbinBirmingham$8K
- Robert StiboltBirmingham$5K
- Jeong Mi ParkBirmingham$5K
- Jessica ZarzourBirmingham$5K
- Edgar UnderwoodBirmingham$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.